Canopy Growth CGC
NASDAQ CGC
$1.02 -0.01 (-1.44%)
At close: Aug 20, 2026 · 12:57 PM UTC

Canopy Growth (CGC) Consolidated Net Income (2019 - 2026)

Canopy Growth (CGC) posted Consolidated Net Income of -$3.6 million for Q3 2025, down 251.5% sequentially from $2.4 million in Q3 2024, and down 251.5% YoY from $2.4 million in Q3 2024.

Canopy Growth (CGC) Consolidated Net Income (2019 - 2026) Analysis & Trends

Canopy Growth has reported Consolidated Net Income for 7 years, with the latest figure at -$3.6 million in Q3 2025.

  • Quarterly Consolidated Net Income fell 251.5% year-over-year to -$3.6 million in Q3 2025, while the trailing twelve-month figure through Mar 2026 was -$3.6 million (down 193.02% YoY) and the FY2025 annual result came in at -$55.2 million, changed N/A from the prior year.
  • Consolidated Net Income retreated to -$3.6 million in Q3 2025 per CGC's latest filing, from $2.4 million in the prior quarter.
  • Over five years, Consolidated Net Income peaked at $317.2 million in Q2 2021 and troughed at -$1.6 billion in Q2 2022.
  • A 5-year average of -$138.9 million and a median of -$25.5 million in 2022 frame the typical range for Consolidated Net Income.
  • The sharpest annual moves came in 2021 and 2022: Consolidated Net Income surged 442.79% in 2021, then tumbled 617.16% in 2022.
  • Over 5 years, Consolidated Net Income stood at -$91.6 million in 2021, then surged by 69.82% to -$27.6 million in 2022, then jumped by 135.81% to $9.9 million in 2023, then slumped by 75.89% to $2.4 million in 2024, then plunged by 251.5% to -$3.6 million in 2025.
  • According to Business Quant data, Consolidated Net Income over the past three periods registered -$3.6 million, $2.4 million, and $1.5 million for Q3 2025, Q3 2024, and Q2 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Haleon 43.96 Bn 43.00 Bn - -
2 Teva Pharmaceutical Industries 43.23 Bn 39.58 Bn 2.15 Bn -576.00 Mn
3 Zoetis 31.76 Bn 30.08 Bn 1.05 Bn 866.00 Mn
4 Takeda Pharmaceutical 28.68 Bn 22.88 Bn 5.10 Bn 1.33 Bn
5 United Therapeutics 22.27 Bn 19.61 Bn 683.80 Mn 333.00 Mn
6 Viatris 18.69 Bn 17.81 Bn 1.46 Bn -118.80 Mn
7 Neurocrine Biosciences 15.56 Bn 15.17 Bn 935.80 Mn 144.40 Mn
8 Elanco Animal Health 11.78 Bn 11.25 Bn 798.00 Mn 54.00 Mn
9 Dr Reddys Laboratories 10.13 Bn 9.97 Bn - -
10 Canopy Growth 434.93 Mn 187.92 Mn 16.08 Mn -10.54 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -10.54 Mn
Sep 30, 2025 -3.62 Mn
Sep 30, 2024 2.39 Mn
Jun 30, 2024 1.50 Mn
Mar 31, 2024 1.74 Mn
Dec 31, 2023 9.90 Mn
Sep 30, 2023 -131.76 Mn
Jun 30, 2023 -23.30 Mn
Mar 31, 2023 -44.10 Mn
Dec 31, 2022 -27.65 Mn
Sep 30, 2022 -83.84 Mn
Jun 30, 2022 -1.64 Bn
Mar 31, 2022 -408.19 Mn
Dec 31, 2021 -91.63 Mn
Sep 30, 2021 -12.97 Mn
Jun 30, 2021 317.24 Mn
Mar 31, 2021 -87.57 Mn
Dec 31, 2020 -636.08 Mn
Sep 30, 2020 -72.45 Mn
Jun 30, 2020 -92.55 Mn